Xizang Haisco Pharmaceutical Group Co Ltd (002653) - Total Liabilities
Based on the latest financial reports, Xizang Haisco Pharmaceutical Group Co Ltd (002653) has total liabilities worth CN¥2.99 Billion CNY (≈ $437.31 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Xizang Haisco Pharmaceutical Group Co Lt cash flow conversion to assess how effectively this company generates cash.
Xizang Haisco Pharmaceutical Group Co Ltd - Total Liabilities Trend (2008–2024)
This chart illustrates how Xizang Haisco Pharmaceutical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Xizang Haisco Pharmaceutical Group Co Lt to evaluate the company's liquid asset resilience ratio.
Xizang Haisco Pharmaceutical Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Xizang Haisco Pharmaceutical Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cognex Corporation
NASDAQ:CGNX
|
USA | $524.65 Million |
|
Acuity Brands Inc
NYSE:AYI
|
USA | $1.86 Billion |
|
Sinotruk (Hong Kong) Limited
F:4SK
|
Germany | €88.97 Billion |
|
Autoliv Inc
ST:ALIV-SDB
|
Sweden | Skr6.05 Billion |
|
Generac Holdings Inc
NYSE:GNRC
|
USA | $2.95 Billion |
|
Sibanye Gold Ltd ADR
NYSE:SBSW
|
USA | $100.35 Billion |
|
Medibank Private Ltd
AU:MPL
|
Australia | AU$1.92 Billion |
Liability Composition Analysis (2008–2024)
This chart breaks down Xizang Haisco Pharmaceutical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Xizang Haisco Pharmaceutical Group Co Lt worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.76 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.71 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Xizang Haisco Pharmaceutical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2024)
The table below shows the annual total liabilities of Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥2.60 Billion ≈ $379.90 Million |
+4.59% |
| 2023-12-31 | CN¥2.48 Billion ≈ $363.25 Million |
-14.77% |
| 2022-12-31 | CN¥2.91 Billion ≈ $426.19 Million |
+39.68% |
| 2021-12-31 | CN¥2.09 Billion ≈ $305.11 Million |
-2.65% |
| 2020-12-31 | CN¥2.14 Billion ≈ $313.42 Million |
-19.44% |
| 2019-12-31 | CN¥2.66 Billion ≈ $389.04 Million |
+12.10% |
| 2018-12-31 | CN¥2.37 Billion ≈ $347.03 Million |
+10.90% |
| 2017-12-31 | CN¥2.14 Billion ≈ $312.94 Million |
+47.51% |
| 2016-12-31 | CN¥1.45 Billion ≈ $212.15 Million |
+35.38% |
| 2015-12-31 | CN¥1.07 Billion ≈ $156.71 Million |
+39.53% |
| 2014-12-31 | CN¥767.55 Million ≈ $112.32 Million |
+44.75% |
| 2013-12-31 | CN¥530.24 Million ≈ $77.59 Million |
+122.33% |
| 2012-12-31 | CN¥238.49 Million ≈ $34.90 Million |
+107.48% |
| 2011-12-31 | CN¥114.95 Million ≈ $16.82 Million |
-34.98% |
| 2010-12-31 | CN¥176.79 Million ≈ $25.87 Million |
-17.47% |
| 2009-12-31 | CN¥214.22 Million ≈ $31.35 Million |
+54.41% |
| 2008-12-31 | CN¥138.73 Million ≈ $20.30 Million |
-- |
About Xizang Haisco Pharmaceutical Group Co Ltd
Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. The company offers pharmaceutical products in the areas of anesthesia and analgesia, diabetes mellitus and complications, tumor, neuralgia, parenteral nutrition, cardio-cerebrovascular, digestive and respiratory, narcotic analgesics, endocrine system, enteral parenteral,… Read more